期刊文献+

重型再生障碍性贫血患者并发真菌感染的临床观察 被引量:10

Severe Type Aplastic Anemia with Fungal Infection: A Clinical Observation
下载PDF
导出
摘要 目的了解重型再生障碍性贫血(SAA)患者并发真菌感染的临床特征。方法观察我院15年209例SAA患者并发真菌感染的患病率、菌谱、影响因素及预后。结果SAA患者并发真菌感染的患病率为18.18%,其中系统性真菌感染占47.37%;并发真菌感染与白细胞过低、院外长时间应用广谱抗生素有关,与年龄、T细胞亚群、免疫抑制治疗无关;浅部真菌感染以白色念珠菌为主,深部真菌感染以念珠菌及曲霉菌为主,曲霉菌感染有上升趋势;SAA患者并发真菌感染的病死率为34.21%,其中深部真菌感染占61.1%。结论真菌感染是SAA的常见并发症之一,以白色念珠菌及曲霉菌多见,病死率主要与白细胞低及长期应用广谱抗生素有关。 OBJECTIVE To study the clinical characteristics of severe type aplastic anemia (SAA) patients with fungal infection. METHODS The prevalence of fungal infection in 209 SAA cases residenting from 1990 to 2004 in Blood Disease Hospital,CAMS, the fungal spectrum, risk factors and prognosis were analyzed. RESULTS The prevalence of fungalinfection in SAA patients was 18. 18%, in which 47.37% were invasive fungal infection. The risk factors of fungal infection were neutropenia, long-term usage of broad spectrum antibiotics. Patient' s age, T cell subtypes and immunosuppressive treatment were not found to have association with the fungal infection. The fungal infection of skin and mucous membrane was caused mainly by Candida albicans, and the invasive fungal infection was caused by Candida and Aspergillus. Aspergillus infection increased year by year. The total mortality of SAA patients with fungal infection was 34.21%, in which with invasive fungal infection was 61.1%. CONCLUSIONS Fungal infection is one of the common complications of SAA, usually caused by Candida and Aspergillus and associated with leukocytopenia and long-term usage of broad spectrum antibiotics.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2005年第8期866-869,共4页 Chinese Journal of Nosocomiology
基金 天津市自然科学基金资助(003606117)
关键词 重型再生障碍性贫血 感染 真菌 Anemia, aplastic Infection Fungi
  • 相关文献

参考文献12

  • 1卢建平,张翊.医院内真菌感染临床分析[J].中华医院感染学杂志,2004,14(3):344-346. 被引量:95
  • 2吴玉红,邵宗鸿,刘鸿,崔振珠,秦铁军,付蓉,何广胜,施均,白洁,曹燕然,杨天楹,杨崇礼.重型再生障碍性贫血患者并发感染的临床特征[J].中华血液学杂志,2003,24(10):530-533. 被引量:15
  • 3Subir M, Martino R, Rovira M, et al. Clinical applicability of the new EORTC/MSG classification for invasive pulmonary aspergillosis in patients with hematological malignancies and autopsy-confirmed invasive aspergillosis [J]. Ann Hematol,2003,82:80-82.
  • 4Warnock DW. Fungal infections in neutropenia: current problems and chemotherapeutic control [J]. J Antimierob Chemother, 1998,41 : 95-105.
  • 5Pannuti CS, Gingrieh RD, Pfaller MA, et al. Nosoeomial pneumonia in adult patients undergoing bone marrow transplantation: a 9-year study[J]. J Clin Oncol, 1991,9(1):77-84.
  • 6Wingard JR, Merz WG, Rinaldi MG, et al. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole[J]. N Engl J Med,1991,325(18):1274-1277.
  • 7Yonemori K, Takezako N, Nishimura K. Fungal infection in neutropenic patients in a hospital during construction[J]. Jpn J Infect Dis, 2002,126-127.
  • 8Maertens J, Verhaegen J, Demuynck H, et al. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive aspergillosis[J]. J Clin Microbiol, 1999,37(10) : 3223-3228.
  • 9Walsh TJ, Hier DB, Caplan LR. Aspergillosis of the central nervous system: clinicopathological analysis of 17 patients[J].Ann Neurol, 1985,18(5) 1574-582.
  • 10Ruhnke M,Bohme A,Buchheidt D, et al. Diagnosis of invasive fungal infections in hematology and oncology[J]. Ann Hematol, 2003,82(2) : 141-148.

二级参考文献15

  • 1Young N, Maciejewski JP. Hematology principles and practice. 3rd ed.Harcourt Asia: Churchill Livingstone,2001. 297-322.
  • 2Tenssaie ZW. Multiple antimicrobial resistance in gram-negative bacilii isolated from clinical specimen ,Jimma Hospital ,southwest Ethiopia.Ethiop Med J,2001,39:305-312.
  • 3Comely OA, Ullmann AJ,Karthaus M.Antifungal prosphylaxis in neutropenic patients ,Wien Med Wochenschr,2001,151 : 73-79.
  • 4Syptda WT, Kale-Pradhan PB. Therapeutic dilemma of fluconazole prophylaxis in intensive care. Ann Pharmacother, 2002,36:155-159.
  • 5Grigull L, Schrauder A, Schmitt-Thomssen A, et al. Efficacy and safety of G-CSF mobillized graneulocyte transfusion in four neutropenic children with spesis and invasive fungal infection. Infection,2002,30:267-271.
  • 6Lyman GH, Kuderer NM, Djulbegovic B. Prophylactic granulocyte colony-stimulating factor in patients receiving dose-intensive cancer cheraphy:a meta -analysis.Am J Med, 2002,113:766-768.
  • 7Bow EJ, Louie TJ.Changes in endogenous microflora among febrile granulocytopenic patients receiving empiric antibiotic therapy: implications for fungal superinfection[J].CMAJ, 1987, 137(5): 397.
  • 8Liebowitz LD, Ashbee HR, Evans EG, et al. A two year global evaluation of susceptibility of Candida species to fluconazole by disk diffusion[J]. Diagn Microbiol Infect Dis, 2001, 40: 27-33.
  • 9李兰娟,吴瑶.医院内感染及细菌耐药谱研究[J].中华传染病杂志,1998,16(2):97-100. 被引量:45
  • 10杨岚,彭道荣.血液病深部真菌感染的临床分析[J].中华医院感染学杂志,2000,10(3):182-183. 被引量:58

共引文献162

同被引文献109

引证文献10

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部